No Data
No Data
Psyence Biomedical Shares Are Trading Higher. The Company Announced It Has Entered Into an IP Licensing and Mutual Exclusivity Agreement With Optimi Health Corp.
Express News | Psyence Biomed Executes Binding Agreements With Optimi Health Corp.
Optimi Health Secures Certification for 40mg and 60mg MDMA GMP Capsules | CSE:OPTI, OTCQB:OPTHF
Optimi Health Corp. Expands Global Reach With MDMA Export
Early Warning Press Release in Accordance With National Instrument 62-103
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University